Brookville, MD, United States of America

Suzanne L Topalian

USPTO Granted Patents = 16 

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 67(Granted Patents)


Location History:

  • Brookeville, MD (US) (2001 - 2023)
  • Brookville, MD (US) (2021 - 2023)

Company Filing History:


Years Active: 2001-2023

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Suzanne L. Topalian

Introduction

Suzanne L. Topalian is a prominent inventor based in Brookville, MD, who has made significant contributions to the field of cancer immunotherapy. With a remarkable portfolio of 16 patents, she has focused her research on innovative treatments that enhance the body’s immune response against tumors.

Latest Patents

Her latest patents revolve around the concept of checkpoint blockade and microsatellite instability. These patents explore the blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1). Research indicates that using inhibitory antibodies directed at these receptors can break immune tolerance and promote anti-tumor immunity. Notably, these agents demonstrate particularly promising results in patients with certain types of tumors that produce a variety of neoantigens, making them more susceptible to such treatments.

Career Highlights

Throughout her career, Suzanne has held prestigious positions at important institutions, including The Johns Hopkins University and the United States of America as represented by the Secretary of the Department of Health and Human Services. Her work has positioned her as a leading figure in the field of immunology, helping to pave the way for groundbreaking cancer therapies.

Collaborations

Suzanne has collaborated with notable researchers such as Drew M. Pardoll and Luis Diaz. These partnerships have been instrumental in advancing her research and the development of effective cancer treatments. The collaborative efforts underscore the importance of teamwork in driving innovation in the fight against cancer.

Conclusion

In summary, Suzanne L. Topalian exemplifies the spirit of innovation in cancer research. Her extensive patent portfolio and collaborative efforts reflect her commitment to improving patient outcomes through advanced immunotherapy. As research in this field continues to evolve, her contributions will undoubtedly play a crucial role in shaping future therapies for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…